Marginal note:Terms and conditions — clinical trial authorizations
3.2 The holder of an authorization referred to in section 3.1 shall comply with any terms and conditions of the authorization that are imposed by the Minister under regulations made under paragraph 30(1)(b.3).
- 2019, c. 29, s. 166
Version in force since May 23, 2020